Making Sense of the Evolving Standards of Care for Advanced HER2+ Breast Cancer

Credits Available:

1.0 AMA PRA Category 1 Credit(s)™: 1.0 contact hour of continuing pharmacy education credit; 1.0 contact hour for nurses

• Making Sense of the Evolving Standards of Care for Advanced HER2 Positive Breast Cancer - Baseline Assessment

  Assess your baseline knowledge and competency regarding the sequencing of HER2-directed therapies, recognition of the frequency of brain metastases, use of HER2 directed therapies in women with brain metastases, managing adverse events, and improving adherence.

• Self-Study Chapter 1: Advanced HER2 Positive Breast Cancer Select Treatment Options

  In this micro-activity, participants will review sequencing of HER2-directed therapies, recognize the frequency of brain metastases, and explore the use of HER2 directed therapies in women with brain metastases.

• Self-Study Chapter 2: Treatment-related Adverse Events

  In this micro-activity, participants will examine solutions for monitoring and managing treatment-related adverse events in patients with HER2-breast cancer receiving novel targeted therapies.

• Self-Study Chapter 3: Strategies to Improve Treatment Adherence

  In this micro-activity, participants will review strategies to improve treatment adherence in HER2-positive metastatic breast cancer.

• Making Sense of the Evolving Standards of Care for Advanced HER2 Positive Breast Cancer - Final Assessment

  Assess your knowledge and competency regarding the sequencing of HER2-directed therapies, recognition of the frequency of brain metastases, use of HER2 directed therapies in women with brain metastases, managing adverse events, and improving adherence.

• Live Web Meeting 1

  This live meeting will consist of a Group Leader-led discussion on best practices related to treatment selection, monitoring and managing treatment related adverse events, and adherence challenges in patients with HER2-positive metastatic breast cancer.

• Live Web Meeting 2

  This live meeting will consist of a Group Leader-led discussion to review key points from the group task and address group member questions and/or low scoring items on the baseline assessment.

• “Making Sense of the Evolving Standards of Care for Advanced HER2+ Breast Cancer”

  This group task involves the presentation of an authentic case scenario of an HER2+ metastatic breast cancer patient. Each participant will be assigned to describe one aspect of the comprehensive management of the case.

Thank you for your interest. Currently, the curriculum is closed for enrollment but we encourage you to keep an eye out for future opportunities or alternative programs that might align with your educational goals.

View Other Offerings